Use of the BIG score to predict mortality in pediatric trauma.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
07 2021
Historique:
received: 27 01 2020
revised: 14 09 2020
accepted: 24 09 2020
pubmed: 21 10 2020
medline: 27 8 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

The BIG score, which is comprised of admission base deficit (B), International Normalized Ratio (I), and GCS (G), is a severity of illness score that can be used to rapidly predict in-hospital mortality in pediatric patients presenting following traumatic injury. We sought to compare the mortality prediction of the pediatric trauma BIG score with other well-established pediatric trauma severity of illness scores: the pediatric logistic organ dysfunction (PELOD); the pediatric index of mortality 2 (PIM2); and the pediatric risk of mortality (PRISM III). In this retrospective cohort study, data from 2009 to 2015 was collected using a multi-institutional database. All pediatric patients admitted following traumatic injury with a recorded initial GCS were included. BIG, PELOD, PIM2, and PRISM III scores were calculated, and Receiver Operator Characteristic curves were derived for all severity of illness scores. Mortality prediction performance for each score was compared by the area under the curve (AUC). A total of 29,204 patients were included in this analysis. AUC for BIG, PELOD, PIM2, and PRISM III scores were 0.97 (0.97-0.98), 0.98 (0.98-0.98), 0.98 (0.97-0.98), and 0.99 (0.98-0.99), respectively. At the optimum cut-off point of 16, the BIG score had a sensitivity of 0.937, specificity of 0.938, positive predictive value of 0.514, and negative predictive value of 0.995. In this massive cohort of pediatric trauma patients, the BIG score using imputation of missing variables performed similarly to the PELOD, PIM2, and PRISM III, further validating the score as a predictor of mortality.

Identifiants

pubmed: 33077313
pii: S0735-6757(20)30855-X
doi: 10.1016/j.ajem.2020.09.060
pii:
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-475

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Jeff Bolstridge (J)

Brooke Army Medical Center, Department of Pediatrics, MCHE-ZDP, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, United States of America. Electronic address: jeffrey.m.bolstridge.mil@mail.mil.

Erika R O'Neil (ER)

Baylor College of Medicine, Section of Critical Care Medicine, 6651 Main St., Legacy Tower, MC:E1420, Houston, TX 77030, United States of America. Electronic address: erika.bernardo@bcm.edu.

James K Aden (JK)

Brooke Army Medical Center, Department of Pediatrics, MCHE-ZDP, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, United States of America. Electronic address: james.k.aden2.civ@mail.mil.

Teddy Muisyo (T)

Washington University School of Medicine, The Division of Pediatric Critical Care Medicine, 4905 Children's Place, St. Louis, MO 63110, United States of America.

Philip C Spinella (PC)

Washington University School of Medicine, The Division of Pediatric Critical Care Medicine, 4905 Children's Place, St. Louis, MO 63110, United States of America. Electronic address: pspinella@wustl.edu.

Matthew A Borgman (MA)

Brooke Army Medical Center, Department of Pediatrics, MCHE-ZDP, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH